Aldebaran Capital »

Reneo Pharmaceuticals shares owned by Aldebaran Capital

Quarter-by-quarter ownership of Reneo Pharmaceuticals (RPHM) shares owned by Aldebaran Capital from 13F filings

Historical chart of Aldebaran Capital investment in Reneo Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Reneo Pharmaceuticals held by Aldebaran Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Reneo Pharmaceuticals by Aldebaran Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $658k 396k 1.66

More positions owned by Aldebaran Capital

Berkshire Hathaway Inc Del Cl B New (BRK.B)
Occidental Petroleum Corporation (OXY)
Bunge
Microsoft Corporation (MSFT)
Eli Lilly & Co. (LLY)
Bank of America Corporation (BAC)
Cato Corp Cl A (CATO)
Ishares Tr Rus Mdcp Val Etf (IWS)
Suncor Energy (SU)
Chevron Corporation (CVX)
Abrdn Etfs Bbrg All Comd K1 (BCI)
JPMorgan Chase & Co. (JPM)
Hillenbrand (HI)
Verizon Communications (VZ)
Enbridge (ENB)

View all positions for Aldebaran Capital

Top funds holding Reneo Pharmaceuticals

NEA Management Company
Tang Capital Management
Highbridge Capital Management
Carlyle
RiverVest Venture Management
Octagon Capital Advisors
BML Capital Management
BlackRock
Vanguard Group
Aisling Capital Management
Rock Springs Capital Management
Renaissance Technologies
Acuitas Investments
Aldebaran Capital
Geode Capital Management

View all funds holding Reneo Pharmaceuticals